Oct 23, 2018
We appreciate the opportunity to provide our comments on the September 24th draft report, “Biologic Therapies for Treatment of Asthma Associated with Type 2 Inflammation: Effectiveness, Value, and Value-Based Price Benchmarks.” At the outset, we want to raise a...
